147 related articles for article (PubMed ID: 17033617)
1. Diabetes and the risk of prostate cancer: the role of diabetes treatment and complications.
Velicer CM; Dublin S; White E
Prostate Cancer Prostatic Dis; 2007; 10(1):46-51. PubMed ID: 17033617
[TBL] [Abstract][Full Text] [Related]
2. Diabetes and risk of prostate cancer in a prospective cohort of US men.
Rodriguez C; Patel AV; Mondul AM; Jacobs EJ; Thun MJ; Calle EE
Am J Epidemiol; 2005 Jan; 161(2):147-52. PubMed ID: 15632264
[TBL] [Abstract][Full Text] [Related]
3. Antidiabetic medication and prostate cancer risk: a population-based case-control study.
Murtola TJ; Tammela TL; Lahtela J; Auvinen A
Am J Epidemiol; 2008 Oct; 168(8):925-31. PubMed ID: 18700234
[TBL] [Abstract][Full Text] [Related]
4. Cancer risks in thiazolidinedione users compared to other anti-diabetic agents.
Koro C; Barrett S; Qizilbash N
Pharmacoepidemiol Drug Saf; 2007 May; 16(5):485-92. PubMed ID: 17192841
[TBL] [Abstract][Full Text] [Related]
5. Vitamin E and selenium supplementation and risk of prostate cancer in the Vitamins and lifestyle (VITAL) study cohort.
Peters U; Littman AJ; Kristal AR; Patterson RE; Potter JD; White E
Cancer Causes Control; 2008 Feb; 19(1):75-87. PubMed ID: 17943452
[TBL] [Abstract][Full Text] [Related]
6. Recreational physical activity and prostate cancer risk (United States).
Littman AJ; Kristal AR; White E
Cancer Causes Control; 2006 Aug; 17(6):831-41. PubMed ID: 16783611
[TBL] [Abstract][Full Text] [Related]
7. Is diabetes mellitus associated with prostate cancer incidence and survival?
Will JC; Vinicor F; Calle EE
Epidemiology; 1999 May; 10(3):313-8. PubMed ID: 10230844
[TBL] [Abstract][Full Text] [Related]
8. Alcohol use and the risk of prostate cancer: results from the VITAL cohort study.
Velicer CM; Kristal A; White E
Nutr Cancer; 2006; 56(1):50-6. PubMed ID: 17176217
[TBL] [Abstract][Full Text] [Related]
9. Cimetidine use and the risk for prostate cancer: results from the VITAL cohort study.
Velicer CM; Dublin S; White E
Ann Epidemiol; 2006 Dec; 16(12):895-900. PubMed ID: 16843010
[TBL] [Abstract][Full Text] [Related]
10. Anthropometrics and prostate cancer risk.
Littman AJ; White E; Kristal AR
Am J Epidemiol; 2007 Jun; 165(11):1271-9. PubMed ID: 17395597
[TBL] [Abstract][Full Text] [Related]
11. The joint effects of different types of glucose-lowering treatment and duration of diabetes on total and cardiovascular mortality among subjects with type 2 diabetes.
Khalangot M; Tronko M; Kravchenko V; Kulchinska J; Hu G
Diabetes Res Clin Pract; 2008 Oct; 82(1):139-47. PubMed ID: 18703252
[TBL] [Abstract][Full Text] [Related]
12. Medical therapy for diabetes is associated with increased use of lower endoscopy.
Lewis JD; Capra AM; Achacoso NS; Ferrara A; Levin TR; Quesenberry CP; Habel LA
Pharmacoepidemiol Drug Saf; 2007 Nov; 16(11):1195-202. PubMed ID: 17603822
[TBL] [Abstract][Full Text] [Related]
13. The metabolic syndrome is associated with reduced risk of prostate cancer.
Tande AJ; Platz EA; Folsom AR
Am J Epidemiol; 2006 Dec; 164(11):1094-102. PubMed ID: 16968859
[TBL] [Abstract][Full Text] [Related]
14. Thiazolidinediones and the risk of lung, prostate, and colon cancer in patients with diabetes.
Govindarajan R; Ratnasinghe L; Simmons DL; Siegel ER; Midathada MV; Kim L; Kim PJ; Owens RJ; Lang NP
J Clin Oncol; 2007 Apr; 25(12):1476-81. PubMed ID: 17442990
[TBL] [Abstract][Full Text] [Related]
15. The relationship between the exposure time of insulin glargine and risk of breast and prostate cancer: an observational study of the time-dependent effects of antidiabetic treatments in patients with diabetes.
Lind M; Fahlén M; Eliasson B; Odén A
Prim Care Diabetes; 2012 Apr; 6(1):53-9. PubMed ID: 22056422
[TBL] [Abstract][Full Text] [Related]
16. Insulin use is not significantly predictive for prostate cancer mortality in diabetic patients: a 12-year follow-up study.
Tseng CH
BJU Int; 2012 Sep; 110(5):668-73. PubMed ID: 22300458
[TBL] [Abstract][Full Text] [Related]
17. Association of vasectomy and prostate cancer among men in a Maryland cohort.
Rohrmann S; Paltoo DN; Platz EA; Hoffman SC; Comstock GW; Helzlsouer KJ
Cancer Causes Control; 2005 Dec; 16(10):1189-94. PubMed ID: 16215869
[TBL] [Abstract][Full Text] [Related]
18. Body mass index, weight change, and risk of prostate cancer in the Cancer Prevention Study II Nutrition Cohort.
Rodriguez C; Freedland SJ; Deka A; Jacobs EJ; McCullough ML; Patel AV; Thun MJ; Calle EE
Cancer Epidemiol Biomarkers Prev; 2007 Jan; 16(1):63-9. PubMed ID: 17179486
[TBL] [Abstract][Full Text] [Related]
19. Dietary acrylamide intake and prostate cancer risk in a prospective cohort of Swedish men.
Larsson SC; Akesson A; Wolk A
Cancer Epidemiol Biomarkers Prev; 2009 Jun; 18(6):1939-41. PubMed ID: 19505926
[TBL] [Abstract][Full Text] [Related]
20. Diabetes patients requiring glucose-lowering therapy and nondiabetics with a prior myocardial infarction carry the same cardiovascular risk: a population study of 3.3 million people.
Schramm TK; Gislason GH; Køber L; Rasmussen S; Rasmussen JN; Abildstrøm SZ; Hansen ML; Folke F; Buch P; Madsen M; Vaag A; Torp-Pedersen C
Circulation; 2008 Apr; 117(15):1945-54. PubMed ID: 18378618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
